Deutsche Bank Downgrades Syneos Health to Hold, Lowers Price Target to $43

Benzinga · 05/11/2023 09:05
Deutsche Bank analyst Justin Bowers downgrades Syneos Health (NASDAQ:SYNH) from Buy to Hold and lowers the price target from $51 to $43.